Crossmark

Conversion from Radical Esophagectomy to Definitive Chemoradiotherapy After Neoadjuvant Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: Treatment Options Based on Chemotherapy Response

Crossref DOI link: https://doi.org/10.1245/s10434-025-16955-0

Published Online: 2025-02-14

Published Print: 2025-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Narita, Kiyoshi

Higaki, Eiji https://orcid.org/0000-0002-6855-0100
Abe, Tetsuya

Fujieda, Hironori

Hashimoto, Shingo

Kadowaki, Shigenori

Tajika, Masahiro

Kodaira, Takeshi

Muro, Kei

Shimizu, Yasuhiro
License Information

Text and Data Mining valid from 2025-02-14

Version of Record valid from 2025-02-14
More Information

Article History

Received: 1 July 2024

Accepted: 16 January 2025

First Online: 14 February 2025

Disclosure

: Research funding to Kei Muro’s institution was provided by Amgen, MSD, Taiho Pharmaceutical, PRA Health Sciences, and Chugai Pharmaceutical. The remaining authors have no conflicts of interest.

Document is current

Any future updates will be listed below